Analysis of the α4β1 integrin–osteopontin interaction

ST Barry, SB Ludbrook, E Murrison… - Experimental cell research, 2000 - Elsevier
ST Barry, SB Ludbrook, E Murrison, CMT Horgan
Experimental cell research, 2000Elsevier
The integrin α4β1 is involved in mediating exfiltration of leukocytes from the vasculature. It
interacts with a number of proteins up-regulated during the inflammatory response including
VCAM-1 and the CS-1 alternatively spliced region of fibronectin. In addition it binds the
multifunctional protein osteopontin (OPN), which can act as both a cytokine and an
extracellular matrix molecule. Here we map the region of human OPN that supports cell
adhesion via α4β1 using GST fusion proteins. We show that α4β1 expressed in J6 cells …
The integrin α4β1 is involved in mediating exfiltration of leukocytes from the vasculature. It interacts with a number of proteins up-regulated during the inflammatory response including VCAM-1 and the CS-1 alternatively spliced region of fibronectin. In addition it binds the multifunctional protein osteopontin (OPN), which can act as both a cytokine and an extracellular matrix molecule. Here we map the region of human OPN that supports cell adhesion via α4β1 using GST fusion proteins. We show that α4β1 expressed in J6 cells interacts with intact OPN when the integrin is in a high activation state, and by deletion mapping that the α4β1 binding region in OPN lies between amino acid residues 125 and 168 (aa125–168). This region contains the central RGD motif of OPN, which also interacts with integrins αvβ3, αvβ5, αvβ1, α8β1, and α5β1. Mutating the RGD motif to RAD had no effect on the interaction with α4β1. To define the binding site the region incorporating aa125–168 was divided into 5 overlapping peptides expressed as GST fusion proteins. Two peptides supported adhesion via α4β1, aa132–146, and aa153–168; of these only a synthetic peptide, SVVYGLR (aa162–168), derived from aa153–168 was able to inhibit α4β1 binding to CS-1. These data identify the motif SVVYGLR as a novel peptide inhibitor of α4β1, and the primary α4β1 binding site within OPN.
Elsevier